moray

About Moray Wright

Moray is Chief Operating Officer of Parkwalk, which he co-founded in 2009.

8 March 2017

Ceres Power – Half Year Results

By |March 8th, 2017|

08 Mar 2017

New partners, new markets and a growing international presence – INCLUDING FIRST PRODUCT LAUNCH PARTNER
Ceres Power Holdings plc (“Ceres Power”, the “Company” or the “Group”) (AIM: CWR.L), a world leading developer of low cost, next generation fuel cell technology, announces its half-yearly results for the six months ended 31 December 2016.
Highlights
·     New […]

Boxarr catches Bloomberg’s eye

By |March 3rd, 2017|

“BOXARR is exactly the kind of brainy exporter that U.K. politicians of all stripes say they want to encourage.”

 Image courtesy of Bloomberg,com
BOXARR is one of four companies that Bloomberg will follow throughout the two-year BREXIT process, during which the U.K. will depart the EU and define a new relationship with its most important trading partners.
 Read […]

28 February 2017

Sphere Medical – Results for the year ended 31 December 2016

By |February 28th, 2017|

Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, announces its results for the year ended 31 December 2016.
 
Business highlights for 2016 and post year-end
 
·        Successful commercial launch of Proxima 4 in mid-December 2016 in Europe with encouraging early market reaction
·        First sales of Proxima 4 achieved
·        Over 20 […]

Parkwalk closes PhoreMost follow-on investment

By |February 28th, 2017|

We are pleased to announce that Parkwalk has made an investment in Phoremost, a Cambridge University spinout, as part of a Series ‘B’ round of equity funding, alongside Amadeus Capital Partners and the University. Phoremost’s mission is to accelerate, diversify and rationalise drug discovery.

PhoreMost has developed a next-generation phenotypic screening platform called ‘SiteSeeker’ to identify […]

Arkivum and UKCloud announce partnership for public sector archiving

By |February 28th, 2017|

28 Feb 2017

Arkivum, a provider of long term digital safeguarding and preservation solutions and UKCloud, a Cloud Service Provider focused exclusively on the UK Public Sector, today announced a partnership to leverage the growing requirements for long term data management strategies within the UK public sector. Arkivum has been appointed as a Preferred Partner […]

8power – Joins the LoRa Alliance™

By |February 17th, 2017|

8power is pleased to announce membership of the LoRa Alliance™, a global industry group to promote the development and deployment of the LoRaWAN™ Low Power Wide Area Network (LPWAN) open standard. The Alliance represents many of the leading players in the wireless Internet of Things community, including global enterprises, major network operators, service providers, […]

Congenica – Parkwalk closes investment

By |February 15th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund and the Parkwalk Technology Fund VII have invested in a $10m Series ‘B’ financing round for Congenica Limited, which spun out of the Wellcome Trust Sanger Institute and Department of Health. Congenica has developed software that enables the accurate, rapid and scalable clinical interpretation of […]

Sphere Fluidics – Parkwalk closes further funding round

By |February 15th, 2017|

We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously.

Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.

The company was founded on IP generated by the University of Cambridge and has […]

Covatic – University of Oxford Innovation Fund III investment

By |February 15th, 2017|

Covatic is building the world’s first broadcast personalisation engine, based on world-leading IP from the University of Oxford in the field of semantic linked-data technology.  It will enable broadcasters to deliver context aware, dynamic programming tailored to the unique requirements of each audience member.

The company was founded in early 2017 by a combination of […]

Focal Point Positioning – University of Cambridge Enterprise Fund IV investment

By |February 15th, 2017|

Focal Point was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team had originally worked on a range of platforms seeking to improve the navigational and positioning systems on vehicles as diverse as submarines and Martian rovers. They then decided to bring that 30 years of combined knowledge to bear […]

Parkwalk wins at EISA Awards

By |February 2nd, 2017|

Parkwalk are delighted to have won both the ‘Best Investment Exit’ and ‘Best EIS Fund Manager’ categories at the EISA awards on the 1st February 2017. The awards recognised an extremely strong 2016 for Parkwalk. They were presented at the House of Lords to firms, advisers, companies and individuals that achieved outstanding performance in the context […]

27 January 2017

Itaconix (Revolymer) – Joint development agreement with AkzoNobel

By |January 27th, 2017|

Itaconix (formerly caller Revolymer plc) is pleased to announce that its wholly owned US subsidiary, Itaconix Corporation (“Itaconix”), has signed a joint development agreement with Akzo Nobel Chemicals International B.V. (“AkzoNobel”) to advance commercial collaborations in certain applications for the Itaconix itaconic acid polymer technology platform.

The agreement establishes a broad operating framework for the […]

Polypharmakos – University of Cambridge Enterprise Fund IV investment

By |January 17th, 2017|

Cambridge and Kew join forces to find new antimicrobial substances in plants
The Parkwalk-mamanged University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the Royal Botanic Gardens, Kew.
Polypharmakos’s mission is to screen natural-product sources of plant, fungal and insect origin for […]

Fuel3D unveils super-fast 360-degree 3D scanner

By |January 5th, 2017|

High-resolution color scanner enables 3D scanning in 0.3 seconds for applications including AR/VR/gaming, retail and biometrics

Fuel3D, a leading 3D capture and imaging innovator, today announced the details of a new 360-degree scanner. The Fuel3D 360 Scanner is a high-speed imaging and measurement system, designed for capturing highly detailed 360-degree 3D data.

In just 0.3 seconds, […]

Salunda – IGas trial proves the measure of success for hand-held drilling fluid sensor

By |January 3rd, 2017|

AN initial field trial of an advanced hand-held analyser has revealed its potential for the rapid and effective testing and measurement of oil and gas drilling fluids.

Independent oil and gas exploration and production company IGas Energy plc develops onshore oil and gas fields and produces more than 2,500 barrels of oil equivalent per day […]

22 December 2016

Cytora – Parkwalk closes follow-on Investment

By |December 22nd, 2016|

We are pleased to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund  have closed an investment into Cytora, a geopolitical risk analytics spin-out from the University of Cambridge.

Cytora is a pioneer in event detection, whose risk analytics technology is deployed in some of the largest companies and governments in […]

Tangentix – Follow on Investment

By |December 17th, 2016|

We have recently closed a follow on investment into Tangentix for the Parkwalk Opportunities Fund.

Tangentix transforms PC gaming by offering free trial, in-game rental and purchase options.

The company’s proprietary algorithms make downloads up to 3x faster, which means that downloads can reach a wider audience, gamers can buy more games, and publishers benefit from deeper links to […]

Parkwalk and IP Group join forces in UK University Spin-Outs

By |December 16th, 2016|

IP Group plc acquires Parkwalk, the UK’s largest EIS growth fund manager focused on university spin-outs

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, is delighted to announce that it has agreed to acquire Parkwalk Advisors Ltd (“Parkwalk”), the UK’s leading university spin-out focused EIS fund manager.

Founded […]

Brainomix – International Journal of Stroke Publication

By |December 14th, 2016|

Oxford – A new clinical study was conducted by Anglia Ruskin Clinical Trials Unit reporting the performance of e-ASPECTS. In this multi-centre study, non-contrast enhanced computed tomography (NCCT) images from ischemic stroke patients were evaluated by e-ASPECTS and 3 independent neuroradiologists and compared to ground truth ASPECTS scores determined by a core imaging lab. […]

Parkwalk wins ‘Best Generalist’ in the Investment Week 2016/17 Tax Efficiency Awards

By |December 6th, 2016|

Parkwalk are delighted to have won the Investment Week ‘Best Generalist’ in their 2016/17 Tax Efficiency Awards.